MedTrace Logo

Head and Neck cancERs International cOviD-19 collabOraTion

NCT04632173 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2022-03-17

No results posted yet for this study

Summary

To develop an International registry on head and neck cancer patients infected with COVID-19

Conditions

Interventions

OTHER

non interventional study

There is no intervention

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER

  • Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

    collaborator OTHER

  • National Cancer Centre, Singapore

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • University of Birmingham

    collaborator OTHER

  • The University of Queensland

    collaborator OTHER

  • Hellenic Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Evita Fragou · HeCOG

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2022-06-30
Completion
2022-12-30

Countries

  • Greece
  • Italy
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632173 on ClinicalTrials.gov